Arisan organizes primarily around development of therapeutics for neglected and emerging viral diseases, focused on infectious diseases with the potential for significant impact on public health and those classified as priority biodefense-related pathogens. The company's mission is to identify unmet medical needs and provide appropriate solutions through development, collaboration and partnerships to benefit patients with life-threatening infectious diseases. Structured around discovery and development of broad spectrum orally active small-molecule anti-infectives, current programs include a number of antiviral and antibacterial discovery projects
